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Abstract
A greater adherence to the traditional Mediterranean (MED) diet is associated with a reduced risk of developing chronic diseases. This
dietary pattern is based on higher consumption of plant products that are rich in flavonoids. We compared the total flavonoid dietary
intakes, their food sources and various lifestyle factors between MED and non-MED countries participating in the EPIC study. Flavonoid
intakes and their food sources for 35 628 subjects, aged 35–74 years and recruited between 1992 and 2000, in twenty-six study centres were
estimated using standardised 24 h dietary recall software (EPIC-Softw). An ad hoc food composition database on flavonoids was compiled
using analytical data from the United States Department of Agriculture and Phenol-Explorer databases. Moreover, it was expanded to
include using recipes, estimations of missing values and flavonoid retention factors. No significant differences in total flavonoid mean
intake between non-MED countries (373·7 mg/d) and MED countries (370·2 mg/d) were observed. In the non-MED region, the main con-
tributors were proanthocyanidins (48·2 %) and flavan-3-ol monomers (24·9 %) and the principal food sources were tea (25·7 %) and fruits
(32·8 %). In the MED region, proanthocyanidins (59·0 %) were by far the most abundant contributor and fruits (55·1 %), wines (16·7 %) and
tea (6·8 %) were the main food sources. The present study shows similar results for total dietary flavonoid intakes, but significant differ-
ences in flavonoid class intakes, food sources and some characteristics between MED and non-MED countries. These differences
should be considered in studies about the relationships between flavonoid intake and chronic diseases.
Key words: Flavonoids: Intake: Sources: Phenolics: European Prospective Investigation into Cancer and Nutrition
A Mediterranean (MED) diet is the traditional dietary pattern
observed in countries bordering the Mediterranean Sea. It is
characterised by a high consumption of fruits, vegetables,
unrefined cereals, legumes, nuts and seeds, olive oil, a moder-
ate wine consumption and lower intake of animal products.
The MED diet was proposed as a healthy dietary pattern
based on the evidence of its protective role in some chronic
diseases(1–5). As these plant-based products are high in flavo-
noids(6,7), a possible link between flavonoids and reported
health benefits may be considered.
Flavonoids constitute a wide group of secondary plant
metabolites that are ubiquitously distributed in the plant king-
dom. Flavonoids are polyphenolic compounds possessing fif-
teen carbons, with two aromatic rings (rings A and B) joined
by a linear three-carbon chain usually forming a closed
pyran ring (ring C). According to the modifications of the cen-
tral C-ring, they are often divided into six classes: anthocyani-
dins, flavonols, flavanones, flavones, isoflavones and flavanols
or flavan-3-ols, including monomers, proanthocyanidins (PA)
(oligomers and polymers of flavan-3-ol monomers) and flava-
nol-derived compounds (theaflavins and thearubigins)(8).
Despite their low-to-moderate bioavailability, high inter-
and intra-individual variation in absorption and rapid
conjugation(9), flavonoids have been extensively studied in
the last two decades due to their potential health effects,
such as antioxidant, anti-inflammatory, anticarcinogenic,
anti-obesity, anti-allergic and anti-diabetic properties(10,11).
Associations between the consumption of total or classes of
flavonoids and chronic disease prevention have also been
suggested in several case–control and a few cohort
studies(12,13). Epidemiological evidence of the role of flavo-
noid intake against the risk of some chronic diseases is prom-
ising, but not conclusive. Complete descriptive studies of
dietary intake are the first step in the assessment of the poten-
tial relationship between flavonoids and health.
To date, total flavonoid intake has been estimated in a few
descriptive studies (Table 1)(14–24). Moreover, these results
varied widely among the studies because of differences in
the flavonoid classes included, food composition tables used
and dietary assessment methodologies utilised. It is difficult,
therefore, to compare the existing data, and the present total
dietary flavonoid estimations do not yet allow us to conclude
which countries, i.e., MED or non-MED countries, consume
more flavonoids. Hence, the present study aimed to estimate
total flavonoid intake among European adults from MED
and non-MED countries participating in the European
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Table 1. Estimated flavonoid intake in adults in several countries
Study Year Country Population
Dietary
assessment FCDB
Flavonoid
without PA
intake (mg/d)
PA
intake
(mg/d)
Total
flavonoid
intake
(mg/d)
Major class
contributor
Main food
sources Reference
SUVIMAX 1994 France 4942 Dietary history Phenol
explorer*
201 227 428 PA (53 %) Fruits, wine, tea (20)
Stomach cancer
case–control
1997–2007 Italy 777 FFQ USDA† 127‡ 291 417 PA (70 %) Fruits, wine, tea (17)
EPIC 1992–2000 Spain 40 683 Dietary history USDA§ 124‡ 189 313 PA (60 %) Fruits, wine (19)
NHANES 1999–2002 USA 8809 24-HDR USDA† 190‡ 95 285 Flavan-3-ols (64 %) Tea, citrus fruit
juices, fruits
(14,15)
FINDIET 2002 Finland 2007 48-HDR Finnish FCDB 93k 116 209 PA (50 %) Fruits, tea,
chocolate
(16)
EPIC 1994–1999 Greece 28 572 FFQ USDA§ 86‡ 75 161 PA (47 %) Fruits, wine, tea (18)
National
Nutrition
Survey
1995 Australia 17 326 24-HDR USDA† 454‡ Flavan-3-ols (93 %) Tea, fruits (21){
Dutch National
Food
Consumption
Survey
1985 The Netherlands 10 312 Dietary history USDA† 211‡ Flavan-3-ols (69 %) Tea, fruits (23,24){**
Danish
Household
Consumption
Survey
1987 Denmark Dietary history USDA† 175‡ Flavan-3-ols (85 %) Tea, fruits (22){**
FCDB, food composition database; PA, proanthocyanidins; SUVIMAX, SUpple´mentation en VItamines et Mine´raux Anti-oXydants Study; USDA, United States Department of Agriculture; EPIC, European Prospective Investigation
into Cancer and Nutrition; NHANES, National Health and Nutrition Examination Survey; 24-HDR, 24 h dietary recall; FINDIET, National Finnish Diet Study; 48-HDR, 48 h dietary recall.
* Database with dihydroflavonols which were included in total flavonoid intake presented in this table.
† USDA database on flavonoids, version 1, March 2003.
‡ Thearubigins were included in total flavonoid intake presented in this table.
§ USDA database on flavonoids, version 2.1, January 2007.
kTheaflavins and thearubigins were not included in total flavonoid intake presented in this table.
{Calculated taking into account flavonoid intake without PA, because PA intake was not available at the time the study was done.
** Recalculated using USDA databases by Johannot & Somerset(21).
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Prospective Investigation into Cancer and Nutrition (EPIC)
study. Furthermore, the present study also aimed to assess
the main flavonoid food sources and lifestyle characteristics
that could partly explain the flavonoid intake variability
among these countries.
Materials and methods
Study population
The EPIC study is an ongoing prospective cohort study con-
ducted in twenty-three centres throughout ten European
countries to investigate the role of nutrition, lifestyle,
biomarkers and genetic factors in the aetiology of cancer
and other chronic diseases(25,26). A total of 521 448 subjects
(29·4 % men), aged 21–83 years, were enrolled between
1992 and 2000. Most of the participants were recruited from
the general population within defined geographical areas,
with some exceptions: women who were members of a
health insurance programme for state school employees
(France), women attending breast cancer screening (Utrecht,
the Netherlands and Florence, Italy), blood donors (some
centres in Italy and Spain) and vegetarians (the ‘health
conscious’ cohort in Oxford, UK). For the purpose of dietary
analyses, the twenty-three administrative EPIC centres were
redefined into twenty-seven geographical areas(27). A total of
nineteen of the twenty-seven redefined EPIC centres had
both male and female participants, and eight recruited only
women (France; Norway; Utrecht, The Netherlands; and
Naples, Italy).
Dietary data used in the present paper were obtained
from the EPIC calibration study, in which a 24 h dietary
recall (24-HDR) was administered to a stratified random
sample of approximately 8 % (36 994 subjects) of the entire
EPIC cohort(27). A total of 35 628 subjects with 24-HDR data
from twenty-six centres were included in the present analysis,
after exclusion of sixteen subjects due to missing baseline FFQ
data, 941 subjects aged less than 35 years or over 74 years
(because these age groups had low representation) and all
participants from the health conscious group (409 subjects),
because vegetarians and vegans consume a very different
diet from the rest of the cohort(28). The present study was
conducted according to the guidelines laid down in the
Declaration of Helsinki, and all procedures involving human
subjects were approved by ethical review boards from the
International Agency for Research on Cancer (IARC) and all
local participating centres approved the study. Written
informed consent was obtained from all subjects.
Dietary and lifestyle information
Dietary information was obtained through a single standar-
dised 24-HDR interview using computerised software (EPIC-
Softw; International Agency for Research on Cancer)(29,30),
which was administered face-to-face in all centres, except in
Norway, where it was done by telephonic interview(31). In
the EPIC study, about 2000 aggregated food items were
reported per country in the 24-HDR, of which approximately
forty food items were not present in our food composition
database (FCDB). Most of these food items, except coffee sub-
stitutes and cola drinks, do not contain flavonoids in their
composition (such as water, sugar, margarine, caramel, white
chocolate, tonic soft drink, chewing gum, artificial sweetener,
salt and gelatine) or they are infrequently consumed in the
EPIC population (such as bamboo sprouts, carambola, pump-
kin flower, orgeat, rose hips, physalis and vanilla). Data on
other lifestyle factors, including education, anthropometry,
physical activity (combining both occupation, household
and leisure time activities) and smoking history, were col-
lected at baseline through standardised questionnaires and
have been described elsewhere(26,27,32). Data on age, as well
as on body weight and height, were mostly self-reported by
the participants during the 24-HDR interview. The mean
time interval between these baseline measures and the 24-
HDR interview varied by country, from 1 d to 3 years later(27).
Flavonoid Food Composition Database
Our FCDB gathered composition data on six flavonoid classes:
anthocyanidins (cyanidin, delphinidin, malvidin, pelargonidin,
peonidin and petunidin), flavanols (flavan-3-ol monomers
(catechin, epigallocatechin, epicatechin, epicatechin-3-gallate,
epigallocatechin-3-gallate, gallocatechin and catechin-3-gal-
late), PA (dimers, trimers, 4–6-mers, 7–10-mers and .10-mers)
and theaflavins (theaflavin, theaflavin-3,30-digallate,
theaflavin-30-gallate and theaflavin-3-gallate)), flavonols (iso-
rhamnetin, kaempferol, myricetin and quercetin), flavones
(apigenin and luteolin), flavanones (eriodictyol, hesperetin
and naringenin) and isoflavones (daidzein, genistein, glycetin,
biochanin A, formononetin and equol)(33–36). Thearubigins
were not included in the present study because they were
obtained by a non-specific spectrophotometric method(7).
Flavonoid data were mainly obtained from the United States
Department of Agriculture FCDB on flavonoids (version 2.1
released in 2007, although more recently a new version has
been developed in 2011)(7), isoflavones (updated in 2008)(37)
and PA (released in 2004)(38), and the Phenol-Explorer FCDB
(developed in 2009)(6) and the UK Food Standards Agency
FCDB on isoflavones (released in 2010)(39). The United
States Department of Agriculture and Phenol-Explorer FCDB
contain flavonoid data from a systematic and comprehensive
collection of worldwide analytical data. Furthermore, our fla-
vonoid FCDB was expanded by using retention factors, calcu-
lating flavonoid content of recipes, estimating missing values
based on similar foods (by botanical family and plant part),
obtaining consumption data for food group items and employ-
ing botanical data for logical zeros. The retention factors
applied to all flavonoid classes, except isoflavones, were
0·70, 0·35 and 0·25 after frying, cooking in a microwave
oven and boiling, respectively(40). These retention factors
were not applied to isoflavones, because their cooking
losses are usually minimal(41). The final FCDB on flavonoids
contained 1877 food items and 10 % of these food items had
missing values.
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Statistical analyses
Dietary flavonoid values were calculated using generalised
linear models and presented as means with standard errors
stratified by sex and the redefined centres, which were
ordered geographically from south to north. These models
were adjusted for age (continuous variable) and weighted
by season and weekday of the 24-HDR to control for different
distributions of participants across seasons and weekdays of
the recall. The contribution of each individual compound
and class of flavonoids to the total intake was calculated as
a percentage according to the two European regions (MED
countries: all centres in Greece, Spain, Italy and the south of
France; non-MED countries: all centres in the north-east and
north-west of France, Germany, the Netherlands, UK general
population, Denmark, Sweden and Norway). The contribution
of each food group to overall flavonoid intake by European
region was also computed as a percentage.
Differences in flavonoid intakes stratified by European
region were also compared using general linear models
according to the categories of sex, age (35–44, 45–54,
55–64 or 65–74 years), BMI (,25, 25 to ,30 or $30kg/m2),
educational level (none, primary completed, technical/
professional, secondary school or university degree), smoking
status (never smoker, present smoker or former smoker) and
level of physical activity (inactive, moderately inactive, moder-
ately active or active). All these models were adjusted for sex
(categorical), age (continuous), centre (categorical), BMI
(continuous) and energy intake (continuous) and weighted
by season and weekday. P values ,0·05 (two-tailed) were
considered significant. All analyses were conducted using
the SPSS Statistics software (version 19.0; SPSS Inc.).
Results
For both sexes, consumers with the highest total flavonoid
intake were from the UK general population (in men
548·8 mg/d and in women 501·7 mg/d). Meanwhile, consu-
mers with the lowest total flavonoid intake were in Greece
(in men 250·7 mg/d and in women 203·6 mg/d; Fig. 1).
There was no statistically significant difference in flavonoid
intake when adjusted for sex, age, centre, BMI and energy
consumption and weighted by season and weekday of
24-HDR between the MED region (370·2 mg/d) and the non-
MED region (373·7 mg/d; P¼0·349; Table 2). Men had a
statistically higher intake of total flavonoids than women in
MED countries, while the inverse was found in non-MED
countries. Younger people had significantly lower flavonoid
consumption than older people in MED and non-MED
regions. An inverse trend between BMI and total flavonoid
intake was observed in both regions. According to educational
level, participants with technical/professional studies and
university graduates had the highest consumption of
flavonoids in MED and non-MED countries, respectively.
Never and former smokers had the highest flavonoid
intakes in both MED and non-MED countries. Physically
active participants had the highest intakes, particularly in the
MED region.
Table 3 shows the flavonoid class contributors to the total
flavonoid intake. Flavanol class was the main contributor in
both regions, ranging from 72·5 to 75·0 %. More specifically,
in MED countries, PA contributed 59·0 % and flavan-3-ol
monomers only 13·1 %, whereas in non-MED region, PA and
flavan-3-ol monomers contributed 48·2 and 24·9 % respect-
ively. Flavonols, flavanones and anthocyanidins were
intermediate contributors in all regions (7·3–10·1 %). Finally,
the contributions of flavones and isoflavones were minor
(,1·5 %).
The main food sources of dietary flavonoid intake according
to European region are presented in Table 4. In non-MED
countries, tea and fruits were the main food items contributing
25·7 and 32·8 % of total flavonoid intake, respectively. Other
moderate contributors consisted of wines, juices, cereals,
sweets and chocolate products. However, in MED countries,
fruits (55·1 %, mainly apples and pears), wines (16·7 %),
tea (6·8 %) and vegetables (4·5 %) were the most important
food sources.
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Fig. 1. Adjusted daily flavonoid intake (mg/d), stratified by sex and centre ordered from south to north, adjusted for age and weighted by season and weekday
of dietary recall. GRE, Greece; SPA, Spain; ITA, Italy, FRA, France, GER, Germany; NED, The Netherlands; DEN, Denmark; SWE, Sweden; NOR, Norway;
, men; , women. Values are means, with standard errors represented by vertical bars.
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Discussion
The present study is the first large descriptive study presenting
differences in the total dietary flavonoid intake, the related
food sources and socio-demographic and lifestyle determi-
nants between MED and non-MED countries. The results
could be readily compared among centres and among regions,
because a standardised 24-HDR (EPIC-Soft) and a common
flavonoid FCDB were used for the entire EPIC cohort.
In the present study, there was no significant difference in
total flavonoid intake between MED (370·2 mg/d) and non-
MED countries (373·7 mg/d; P,0·349), although a large vari-
ation in flavonoid intake and food sources was observed
among centres. In MED countries, a wide range in total dietary
flavonoids was found, ranging from 203·6 mg/d for Greek
women to 527·6 mg/d for men from Turin (Italy). The highest
flavonoid class contributor was by far PA (59·0 %), with its
main food sources being fruits, wines and tea(35), as was
also reported in an Italian case–control study of gastric
cancer(17) and in the Spanish EPIC cohort(19). Greek men
and women were the lowest flavonoid consumers in the pre-
sent study and these findings are consistent with a recent
study(18). Furthermore, a south to north gradient of increasing
total flavonoids was observed within Spain and Italy, as pre-
viously described in the EPIC-Spain cohort(19). This gradient
could be due to participants in northern areas of MED
countries consuming more apples and pears and red wine
than southern areas(42,43).
In non-MED countries, there was also a broad range of fla-
vonoid intakes from 275·7 mg/d for women from Malmo¨
(Sweden) to 548·8 mg/d for men of the UK general popu-
lation. In this region, the main food sources were clearly tea
(25·7 %) and fruits (32·8 %) and the major flavonoid class con-
tributors were PA and flavan-3-ol monomers. Countries where
tea is widely consumed, such as the UK, The Netherlands,
Denmark or Australia will generally have high flavonoid
Table 2. Estimated mean total flavonoid intake (mg/d) in Mediterranean (MED) and non-MED countries of the European
Prospective Investigation into Cancer and Nutrition cohort by socio-demographic and lifestyle factors*
(Mean values with their standard errors)
MED countries Non-MED countries
Stratification variable n Mean SEM P† n Mean SEM P† P‡
All 11 285 370·2 3·0 24 443 373·7 2·1 0·349
Sex ,0·001 ,0·001
Men 4533 397·7 4·8 8382 335·8 3·6 ,0·001
Women 6752 356·3 3·9 16 061 400·5 2·6 ,0·001
Age (years) ,0·001 ,0·001
35–44 1070 314·3 9·3 2230 341·7 6·5 0·014
45–54 3846 349·6 5·1 8632 368·7 3·5 0·002
55–64 4583 409·1 4·7 10 242 387·9 3·1 ,0·001
65–74 1786 349·9 7·7 3339 367·2 5·5 0·065
BMI (kg/m2) ,0·001 ,0·001
, 25 4037 372·1 5·0 12 596 388·5 3·0 0·005
25 to ,30 4804 370·3 4·5 8895 368·0 3·4 0·709
$ 30 2444 348·0 6·5 2952 338·6 5·8 0·244
Level of schooling ,0·001 ,0·001
No formal education 1639 338·8 8·1 70 299·1 37·5 0·354
Primary completed 4360 366·5 4·9 6109 311·2 4·1 ,0·001
Technical/professional 975 413·5 9·8 7012 366·6 3·8 ,0·001
Secondary school 2297 384·0 6·5 4814 387·1 4·7 0·586
University degree 1902 357·3 7·0 6097 432·8 4·1 ,0·001
Smoking status ,0·001 ,0·001
Never smoker 5927 366·7 4·2 11 386 390·1 3·1 ,0·001
Former smoker 2624 406·0 6·1 7551 389·0 3·6 0·010
Present smoker 2508 345·3 6·2 5193 316·6 4·4 ,0·001
Physical activity ,0·001 ,0·001
Inactive 3668 338·5 5·2 3723 354·9 5·0 0·020
Moderately inactive 3956 368·7 4·8 7889 370·1 3·4 0·878
Moderately active 2280 392·6 6·3 6050 380·8 3·9 0·110
Active 1380 425·4 8·0 4948 389·4 4·3 ,0·001
* Adjusted for sex, age, centre, energy intake and BMI and weighted by season and weekday of recall. P value is for differences in means.
† Differences between each stratification variable in each region.
‡ Differences between MED-countries and non-MED countries.
Table 3. Percentage contribution of classes of total flavonoid intake in
the European Prospective Investigation into Cancer and Nutrition
cohort*
Compound
MED countries
(%)
Non-MED countries
(%)
Anthocyanidins 10·1 7·3
Flavonols 6·7 7·9
Flavanones 9·1 8·5
Flavones 1·5 1·1
Flavanols 72·5 75·0
Flavan-3-ol monomers 13·1 24·9
Proanthocyanidins 59·0 48·2
Theaflavins 0·4 1·9
Isoflavones 0·1 0·2
MED, Mediterranean.
* Adjusted for age, sex and weighted by season and weekday of dietary recall.
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intake, as a result of the sum of flavan-3-ol monomers and
flavanol-derived compounds (theaflavins and thearubigins),
the latter being the highest contributing class(21–24). However,
in the present study, thearubigins were not included because
they were obtained by an unsuitable method(7). Excluding
thearubigins from the analysis, PA became the major flavonoid
contributor in the non-MED region, especially in countries
where tea consumption is less prevalent, for instance, in our
Scandinavian centres (data not shown) or in a recent Finnish
study.(16).
Differences between MED and non-MED countries were
also explained by some socio-demographic, anthropometric
and lifestyle factors. With respect to sex, men had a higher fla-
vonoid intake than women in MED countries as men tend to
drink more wine, particularly red wine(19). However, in non-
MED countries, the opposite was found, as women tended
to consume more tea than men(44). Flavonoid intake was
also shown to increase with age in both these regions(19,44).
Again, the observed differences were largely due to variations
in wine and tea consumption. A US study(14) showed that fla-
vonoid intake increased up to the age group of 51–70 years,
but in the age group .70 years, the consumption decreased
significantly. In the present study, this reduction was also
clearly detected in the oldest age group (65–74 years). Also,
in the present study, participants living in the non-MED
region and having a BMI of less than 25 kg/m2 had a signifi-
cantly higher flavonoid consumption than those in any other
BMI groups. In the MED countries, no statistical difference
was observed between normal and overweight participants
and flavonoid intake. However, in a previous analysis from
the EPIC-Spain cohort, overweight people had the highest
flavonoid intake; the difference was small but statistically
significant(19). In the non-MED region, less-educated adults
had the lowest flavonoid intake, while people with a univer-
sity degree had the highest; thus, flavonoid intake seems to
increase with higher educational level. In contrast, in an US
study, flavonoid intake was higher among those with a
higher poverty income ratio(14). People with a higher edu-
cation and/or income are usually more conscious of good
nutrition and health, so they may take more care of them-
selves and consume more healthy foods such as fresh fruit
and vegetables(45,46). However, in MED countries, the highest
flavonoid intake was observed in the subjects of technical/
professional education, who also tended to have the highest
wine intakes(47). Never and former smokers had a higher
flavonoid intake than present smokers in both MED and
Table 4. Percentage contributions of food groups and some main foods to the intake of
flavonoids by European region*
Food items MED countries (%) Non-MED countries (%)
Potatoes and other tubers 0·1 0·2
Vegetables 4·5 2·1
Leafy vegetables 1·8 0·6
Fruiting vegetables 0·8 0·3
Root vegetables 0·1 0·2
Cabbages 0·1 0·2
Grain and pod vegetables 0·4 0·1
Onion, garlic 0·9 0·5
Other vegetables 0·3 0·2
Legumes 1·4 0·5
Fruits 55·1 32·8
Citrus fruit 7·0 3·7
Apples and pears 25·9 17·2
Grapes 5·6 2·6
Stone fruits 11·7 4·0
Berries 2·9 3·5
Kiwi 0·2 0·1
Other fruits 1·9 1·7
Nuts and seeds 0·7 0·4
Dairy products 0·5 1·1
Cereals, cakes, biscuits and sweets 3·7 6·1
Chocolate products 3·6 4·4
Non-alcoholic beverages 9·4 35·3
Tea 6·8 25·7
Fruit and vegetable juices 2·4 7·1
Other non-alcoholic beverages 0·2 2·5
Alcoholic beverages 19·4 13·0
Wines 16·7 9·8
Beer and cider 2·6 2·6
Other alcoholic beverages 0·1 0·5
Condiments and sauces 0·7 0·6
Soups, bouillons 0·7 3·2
Soya products 0·1 0·1
Meat, fish and eggs 0·0 0·0
Fat and oils 0·0 0·0
* Values are percentages derived from models adjusted for age and sex and weighted by season and
weekday of recall.
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non-MED countries, as was observed previously in the EPIC-
Spain cohort(19). However, smoking status was not associated
with flavonoid intake in the USA(14). In both regions, the trend
of increasing flavonoid intake with more physical activity
was probably observed because physically active people gen-
erally consume more fruits and vegetables, as shown in the
EPIC-Spain cohort(48).
Since the in vitro evidence on health effects of flavonoids
was published(10,11), some epidemiological studies have
reported inverse associations between flavonoid intake and
chronic diseases such as CVD(49) and some cancers(17,50–53).
Despite the comparable flavonoid intakes between MED and
non-MED countries in the present study, there is a well-estab-
lished south to north gradient of CVD mortality(54). This might
be explained in part by the different consumption patterns of
flavonoid classes and their food sources, as observed in the
present study. In addition, other established dietary and life-
style risk factors of CVD are more prevalent in non-MED
countries(5,55,56). Further basic and epidemiological studies
are needed to clarify the potential role of flavonoids against
CVD and other chronic diseases.
The present study has a number of relevant strengths. The
first is the large number of participants in the EPIC calibration
subcohort. The second is the complete list of flavonoids used.
The third strength is the use of the most updated and relatively
large FCDB on worldwide analytical flavonoid data, which
was expanded with plant–plant estimations, thus obtaining
a final database with 1877 food items with only 10 % of
unknown values. The fourth stems from the collection of diet-
ary data using a standardised 24-HDR in the whole cohort(57);
thus, the results are easily comparable across the countries.
Nevertheless, some limitations were encountered. As not all
the EPIC cohorts are population based, these findings
cannot be extrapolated to the general population of each
region(28). A relevant weakness is the likely underestimation
of real flavonoid intake, due to the unknown food flavonoid
composition data (10 % of data in our FCDB and thearubigin
data), and the omission of some food items (such as coffee
substitutes) and herb/plant supplement intakes in the present
analysis (which are up to 5 % of the population in Denmark,
the highest supplement consuming country)(58). Another limi-
tation is the use of a single 24-HDR, which is less likely to
reflect true usual individual diet. However, analyses were
weighted by season and weekday of dietary recall and
24-HDR is a useful method to describe the average dietary
intake of a group, particularly when estimated from a large
number of subjects(59).
In summary, the data obtained in the present study show
total flavonoid intake among the twenty-six EPIC participating
centres in ten European countries. We also describe the major
dietary flavonoid class contributors and the main food sources
that differentiated the MED and non-MED regions. There was
no significant difference in total flavonoid intake between
MED and non-MED countries, although there were differences
in flavonoid classes and their food sources between both
regions. Significant socio-demographic and lifestyle factors
related to total flavonoid intakes were also highlighted by
European region. These descriptive data should be of value
in the future as a first step in dietary flavonoid assessment
and their potential role in health and disease.
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